BridgeMD
New treatment option for Distress, Emotional
Official title Training in Evidence-based Treatments in Psycho-Oncology
ClinicalTrials.gov ID: NCT05674357
What this study is testing
- What it's testing
- The goal of this research study is to train psychotherapists to administer individualized evidence-based psychotherapies in a cancer care setting to patients and caregivers with elevated levels of distress. The intervention will mirror clinical care in psycho-oncology in which the therapist, collaboratively with their supervisor, will choose specific components of the following evidence-based treatments to administer based on the clinical presentation of the patient or caregiver and referring problem.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient
- Adults \> 18 years of age.
- Currently receiving oncology treatment/care at the MGH Cancer Center, including active treatment and/or surveillance.
- Reports elevated levels of distress on the National Comprehensive Cancer Network (NCCN) Distress Thermometer \> 3.
- Reports distress or presenting problem is related to patients' illness and/or treatment (e.g., cancer treatment).
You likely can't join if
- Has uncontrolled psychosis, active suicidal ideation, or psychiatric hospitalization within the past year (assessed through EHR review and screening...
- Has a cognitive impairment that prohibits participation in the study (assessed through EHR review and screening session).
- Currently participating in group or individual evidence-based psychotherapy treatment or other psychosocial intervention trial.
- Has an alcohol or substance dependence (other than nicotine dependence) in the past 8 weeks (assessed through EHR review and screening session using...
See the full eligibility criteria
- Patient
- Adults \> 18 years of age.
- Currently receiving oncology treatment/care at the MGH Cancer Center, including active treatment and/or surveillance.
- Reports elevated levels of distress on the National Comprehensive Cancer Network (NCCN) Distress Thermometer \> 3.
- Reports distress or presenting problem is related to patients' illness and/or treatment (e.g., cancer treatment).
- Has a clinical presentation that matches an evidence-based treatment (e.g., CBT-I for insomnia/sleep disturbance) for cancer-related distress per therapist and supervising therapist discretion.
- Located in the state of Massachusetts for the duration of sessions. Caregiver
- Adults \> 18 years of age
- Currently caring for someone receiving oncology treatment/care at the MGH Cancer Center, including active treatment and/or surveillance
- Reports elevated levels of distress on the National Comprehensive Cancer Network (NCCN) Distress Thermometer \> 3
- Reports distress or presenting problem is related to caregiving
- Has a clinical presentation that matches an evidence-based treatment (e.g., CBT-I for insomnia/sleep disturbance) for caregiving-related distress per therapist and supervising therapist discretion
- Located in the state of Massachusetts for the duration of sessions Patient
- Has uncontrolled psychosis, active suicidal ideation, or psychiatric hospitalization within the past year (assessed through EHR review and screening session using the QuickSCID-5), indicating the need for tailored...
- Has a cognitive impairment that prohibits participation in the study (assessed through EHR review and screening session).
- Currently participating in group or individual evidence-based psychotherapy treatment or other psychosocial intervention trial.
- Has an alcohol or substance dependence (other than nicotine dependence) in the past 8 weeks (assessed through EHR review and screening session using the QuickSCID-5), indicating the need for tailored treatment referral...
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.